Keywords

miRNA-155, connective tissue diseases, diagnosis, treatment

References

[1]       Farh KK, Marson A, Zhu J, et al. (2015). Genetic and epigenetic fine mapping of causal autoimmune disease variants [J]. Nature, 518(7539): 337-343.

[2]       Shooshtari P, Huang H, Cotsapas C. (2017). Integrative Genetic and Epigenetic Analysis Uncovers Regulatory Mechanisms of Autoimmune Disease [J]. Am J Hum Genet, 101(1): 75-86.

[3]       Huntzinger E, Izaurralde E. (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay [J]. Nat Rev Genet, 12(2): 99-110.

[4]       Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 116(2): 281-297.

[5]       Roberts TC. (2015). The microRNA machinery [J]. Adv Exp Med Biol, 887: 15-30.

[6]       Lee RC, Ambros V. (2001). An extensive class of small RNAs in Caenorhabditis elegans [J]. Science, 294(5543): 862-864.

[7]       Bortolin-Cavaille ML, Dance M, Weber M, et al. (2009). C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts [J]. Nucleic Acids Res, 37(10): 3464-3473.

[8]       Cai X, Hagedorn CH, Cullen BR. (2004). Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs [J]. RNA, 10(12): 1957-1966.

[9]       Ballarino M, Pagano F, Girardi E, et al. (2009). Coupled RNA processing and transcription of intergenic primary microRNAs [J]. Mol Cell Biol, 29(20): 5632-5638.

[10]    Han J, Lee Y, Yeom KH, et al. (2004). The Drosha-DGCR8 complex in primary microRNA processing [J]. Genes Dev, 18(24): 3016-3027.

[11]    Baulina NM, Kulakova OG, Favorova OO. (2016). MicroRNAs: the role in autoimmune inflammation [J]. Acta Naturae, 8(1): 21-33.

[12]    Tam W. (2001). Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA [J]. Gene, 22: 274.

[13]    Wu XY, Pais EM, Li Lan, et al. (2017). MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases [J]. Inflammation, 40(2): 708-716.

[14]    Costinean S, Zanesi N, Pekarsky Y, et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice [J]. Proc Natl Acad Sci USA, 103(18): 7024-7029.

[15]    Vigorito E, Perks KL, Abreu-Goodger C, et al. (2007). microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells [J]. Immunity, 27(6): 847-859.

[16]    Leung WH, Tarasenko T, Bolland S. (2009). Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes [J]. Immunol Res, 43(1-3): 243-251.

[17]    O’Connell RM, Chaudhuri AA, Rao DS, et al. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155 [J]. Proc Natl Acad Sci USA, 106(17): 7113-7118.

[18]    Zhang J, Cheng Y, Cui W, et al. (2014). MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis [J]. J Neuroimmunol, 266(1-2), 56-63.

[19]    Blüml S, Bonelli M, Niederreiter B, et al. (2011). Essential role for micro-RNA 155 in the pathogenesis of autoimmune arthritis in mice [J]. Arthritis Rheum, 63(5): 1281-1288.

[20]    Banerjee A, Schambach F, DeJong CS, et al. (2010). Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells [J]. Eur J Immunol, 40(1): 225-231.

[21]    Escobar T, Yu CR, Muljo SA, et al. (2013). STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis [J]. Invest Ophthalmol Vis Sci, 54(6): 4017-4025. 

[22]    Lu LF, Thai TH, Calado DP, et al. (2009). Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein [J]. Immunity, 30(1): 80-91.

[23]    Banerjee A, Schambach F, DeJong CS, et al. (2010). MicroRNAs in the key events of systemic lupus erythematosus pathogenesis [J]. Eur J Immunol, 40(1): 225-231.

[24]    Ceppi M, Pereira PM, Dunand-Sauthier I, et al. (2009). MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells [J]. Proc Natl Acad Sci USA, 106(8): 2735-2740.

[25]    Frisell T, Hellgren K, Alfredsson L, et al. (2016). Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden [J]. Ann Rheum Dis, 75(1): 183-189.

[26]    Elmesmari A, Fraser AR, Wood C et al. (2016). MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis [J]. Rheumatology (Oxford), 55(11): 2056-2065.

[27]    Li X, Tian F, Wang F. (2013). Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-a and IL-1b in PBMCs [J]. Int J Mol Sci, 14(12): 23910–23921.

[28]    Cojocaru M, Cojocaru IM, Silosi I, et al. (2011). Manifestations of systemic lupus erythematosus [J]. Maedica (Buchar), 6(4): 330-336.

[29]    Zhang H, Huang X, Ye L, et al. (2018). B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus [J]. Front Immunol, 9: 1473.

[30]    Liu WH, Kang SG, Huang Z, et al. (2016). A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells [J]. J Exp Med, 213(9): 1901-1919.

[31]    Broen JC, Radstake TR, Rossato M. (2014). The role of genetics and epigenetics in the pathogenesis of systemic sclerosis [J]. Nat Rev Rheumatol, 10(11): 671-681.

[32]    Artlett CM, Sassi-Gaha S, Hope JL, et al. (2017). Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome mediated collagen synthesis during fibrosis [J]. Arthritis Res Ther, 19(1): 144.

[33]    Nair JJ, Singh TP. (2017). Sjögren’s syndrome: review of the aetiology, pathophysiology & potential therapeutic interventions [J]. J Clin Exp Dent, 9(4): e584-e589.

[34]    Reale M, D’Angelo C, Costantini E, et al. (2018). MicroRNA in Sjögren’ssyndrome: Their potential roles in pathogenesis and diagnosis [J]. J Immunol Res, 2018: 7510174.

[35]    Pauley KM, Stewart CM, Gauna AE, et al. (2011). Altered miR-146a expression in Sjögren’s syndrome and its functional role in innate immunity [J]. Eur J Immunol, 41(7): 2029-2039.

[36]    Shi H, Zheng LY, Zhang P, et al. (2014). miR-146a and miR-155 expression in PBMCs from patients with Sjogren’s syndrome [J]. J Oral Pathol Med, 43(10): 792-797.

[37]    Liang CY, Xiong K, Szulwach KE, et al. Sjogren syndrome antigen B (SSB)/La promotes global microRNA expression by binding microRNA precursors through stem-loop recognition [J]. J Biol Chem, 2013, 288(1): 723-736.